Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Clinical trial NCT02038881 · COMPLETED
Trial details
- NCT number
- NCT02038881
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-28
- Primary completion
- 2017-05-10
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.